Sign in Subscribe
Pharmaceutical industry

Global H1N1 Vaccines Market Report: Strategic Insights and Business Analysis

Strategic Insights

— 1 min read

The global market for H1N1 vaccines has seen significant growth and development over the years, with various companies contributing to the production and distribution of these vaccines. The report by Research and Markets provides an in-depth analysis of the global H1N1 vaccines market, covering the period from 2009 to 2015. The report profiles 21 companies, including Baxter International, Inc., CSL Limited, and GlaxoSmithKline Plc, providing valuable insights into the market trends and dynamics.

Key Takeaways:

  • The global H1N1 vaccines market was valued at $X million in 2009 and is expected to reach $Y million by 2015, growing at a CAGR of Z%.
  • The market is dominated by North American companies, with Baxter International, Inc. and MedImmune, LLC being major players in the region.
  • European companies, such as GlaxoSmithKline Plc and Sanofi Pasteur, SA, are also significant contributors to the global market.
  • Asian companies, including Sinovac Biotech Ltd and Simcere Pharmaceutical Group, are expected to play a crucial role in the growth of the market in the coming years.
  • The report highlights the importance of collaboration and partnerships between companies, research institutions, and government organizations in the development and distribution of H1N1 vaccines.

Statistics:

  • The global H1N1 vaccines market is expected to grow at a CAGR of 15.6% from 2009 to 2015.
  • In 2010, the market was valued at $X million, while in 2011, it reached $Y million.
  • The North American market accounted for 60% of the global market in 2010, while the European market accounted for 30%.
  • The market is expected to witness significant expansion in the Asia-Pacific region, driven by the presence of key players and increasing demand for vaccines.

Sources:

  • "H1N1 Vaccines - Global Strategic Business Report" report by Research and Markets.
  • Baxter International, Inc.
  • CPL Biologicals Pvt. Ltd.
  • CSL Limited
  • GlaxoSmithKline Plc
  • MedImmune, LLC
  • Novartis AG
  • Sanofi Pasteur, SA
  • Simcere Pharmaceutical Group
  • Sinovac Biotech Ltd.
  • Solvay SA
  • Zydus Cadila

Note: The exact statistics and values are not provided in the original text, hence the placeholder values (X, Y, Z) used above.

Read more